| Drug Class: | Aromatase Inhibitor |
| Pharmaceutical Name: | Letro-Lab |
| Chemical Name: | Letrozole |
| Chemical Abstract Name: | 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile |
| Molecular Structure: | C17H11N5 |
| Molecular Weight: | 285.303 g/mol |
| Active Half Life: | 2 Days |
| Dosage: | 0.5-2.5 mg/day |
| Acne: | No |
| Water retention: | No |
| High blood pressure: | No |
| Hepatotoxicity: | No |
| Aromatization: | No |
| Hypothalamus-Pituitary-Testes-Axis suppression: | None |
| Manufacturer: | 7Lab Pharma |
| Country: | Switzerland |
| Presentation: | Letro-Lab for sale - 1 x 50 tabs х 2.5 mg |
Commercial Names: Letromina, Letroxyl, Letoripe, Fempro, Mamazol, Femara, Letocor, Feofer, Momazol, Oreta, Letoval, Letz, Letrazole, Zaronil, Letzol, Fematroz, Shantroz, Lets, Letrozol, Letroz, Letronat, Oncolet, Feofar, Letros, Letrova, Trozet.
Please log in to write Letro-Lab review.